A Conserved Gene Signature Predicts Immune Dysregulation and Severe Infection Outcomes


In a new study, researchers have shown that a 42-gene “Signature of Misfiring” (SoM) serves as a robust predictor of immune dysfunction across individuals at high risk of severe infections (Figure 1).

Figure 1: Graphical abstract.

Conducting a large-scale analysis of 12,026 blood samples, the team extended the SoM signature, initially discovered in COVID-19 patients, to a broader population, including older adults, males, individuals with obesity, and those with comorbidities. Remarkably, this signature remained consistently detectable among these high-risk groups, even before infection occurred.

Key Findings:

  • Conserved Across Risk Groups: The SoM signature reliably indicates immune dysregulation tied to demographic and health-related risk factors.
  • Predictive of Clinical Outcomes: Individuals with elevated SoM scores were more likely to benefit from corticosteroid treatments and showed higher all-cause mortality.
  • Implications for Early Intervention: Detecting misregulated immune states before illness could enable clinicians to:
    • Identify individuals most likely to benefit from steroid therapy.
    • Initiate targeted treatment earlier, potentially reducing the severity of eventual infections.

This signature reflects a consistent molecular pattern that links demographic risk factors to underlying immune dysfunction, offering a pathway toward personalised pre-emptive care.Instead of relying solely on observable symptoms or conventional biomarkers, using a molecular signature like this could revolutionise how we:

  • Risk-stratify patients before infection.
  • Tailor preventive therapies, such as corticosteroids, based on individual immune profiles.
  • Enhance patient outcomes, potentially reducing hospitalizations and mortality.

By combining high-throughput transcriptomics with real-world clinical data, this research lays the foundation for a proactive approach to infectious disease, one driven by molecular insight rather than reactive treatment.

Journal article: Ganesan , A., et al. 2025. A conserved immune dysregulation signature is associated with infection severity, risk factors prior to infection, and treatment response. Immunity.

Summary by Stefan Botha

 
 
 
 
 
 
International Union of Immunological SocietiesUniversity of South AfricaInstitute of Infectious Disease and Molecular MedicineElizabeth Glazer Pediatric Aids Foundation